MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3345/cep.2025.00997

Медицинская библиотека · Clinical and experimental pediatrics · 2025

Evaluation of Bak and Bcl-Xl gene expression among pediatric patients with acute primary immune thrombocytopenia.

Badawy Amira Zaki, Kandel Samia Hassan, Ahmedy Iman Aly, Elhawy Mahmoud Ahmed, El-Hefnawy Sally Mohamed, El-Nasr Zidan Dina Fouad Sief, El-Sheity Hanan Hassan

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet counts and an increased risk of bleeding. Moreover, the apoptotic mechanisms of platelets may influence their production and lifespan.

PURPOSE: To assess the involvement of apoptotic markers-specifically the B-cell lymphoma protein 2 family proteins Bak and Bcl-Xl in the pathogenesis of acute primary ITP in pediatric patients, and to evaluate the impact of intravenous immunoglobulin (IVIG) therapy on their expression.

METHODS

This study included 24 children with acute primary ITP and 30 healthy controls. Patients were enrolled from the Hematology and Oncology Unit of Menoufia University Hospitals, Egypt. Two peripheral blood samples were obtained from each participant: one prior to receiving IVIG therapy and the other after treatment. Platelet-rich plasma was isolated, and Bak and Bcl-Xl gene expression levels were assessed using reverse transcription quantitative polymerase chain reaction.

RESULTS

Before treatment, Bak gene expression and Bak/Bcl-Xl expression ratio were significantly higher in patients versus controls (P=0.001 and P<0.001, respectively), whereas Bcl-Xl gene expression was significantly lower (P=0.029). After treatment, Bak gene expression and the Bak/Bcl-Xl expression ratio decreased significantly (P<0.001 and P=0.001, respectively), whereas Bcl-Xl gene expression increased significantly (P<0.001).

CONCLUSION

Pediatric patients with acute primary ITP exhibited a heightened proapoptotic state, as indicated by an increased Bak expression and Bak/Bcl-Xl expression ratio, as well as a reduced Bcl-Xl expression. IVIG therapy appears to mitigate this pro-apoptotic effect, suggesting its ability to restore platelet homeostasis.

Для цитирования: Badawy Amira Zaki, Kandel Samia Hassan, Ahmedy Iman Aly, Elhawy Mahmoud Ahmed, El-Hefnawy Sally Mohamed, El-Nasr Zidan Dina Fouad Sief, El-Sheity Hanan Hassan. Evaluation of Bak and Bcl-Xl gene expression among pediatric patients with acute primary immune thrombocytopenia.. Clinical and experimental pediatrics. 2025. DOI: 10.3345/cep.2025.00997.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.